<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: botulinum toxin</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>No need for needles: Botox sponge treats intrinsic rhinitis</title>
   	 <description>Injecting botulinum toxin (botox) to treat intrinsic or allergic rhinitis may be a thing of the past as researchers have now shown that sponges soaked in botox are equally effective in treating the condition. The research published in BioMed Central's open access journal Head &amp; Face Medicine offers a potential needle-free treatment to the millions of people who suffer from rhinitis.</description>
     <link>http://www.physorg.com/news174853459.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 15 Oct 2009 21:00:01 EST</pubDate>
	 <guid isPermaLink="false">news174853459</guid>
</item>
<item>
     <title>New guidelines identify best treatments to help ALS patients live longer, easier</title>
   	 <description>New guidelines from the American Academy of Neurology identify the most effective treatments for amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease.  The guidelines are published in the October 13, 2009, issue of Neurology, the medical journal of the American Academy of Neurology.</description>
     <link>http://www.physorg.com/news174583624.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 12 Oct 2009 16:29:29 EST</pubDate>
	 <guid isPermaLink="false">news174583624</guid>
</item>
<item>
     <title>Researchers find demand for cosmetic and surgical procedures in dermatologic surgery rising rapidly</title>
   	 <description>Researchers from Boston University School of Medicine (BUSM) and the Laser and Skin Cancer Center of Indiana, (Carmel, Indiana), found that there has been a dramatic increase in the number of procedures performed and patient demand for dermatologic health care since 2000.  The findings, which were recently reported in Dermatologic Surgery, parallels the growth in the age of individuals between the ages of 40 to 55, who make up the "Baby Boomer" generation.</description>
     <link>http://www.physorg.com/news173968864.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 05 Oct 2009 14:00:11 EST</pubDate>
	 <guid isPermaLink="false">news173968864</guid>
</item>
<item>
     <title>Australian stroke victim walks again - with help of botox</title>
   	 <description> An Australian stroke victim paralysed for more than 20 years has walked again thanks to anti-wrinkle drug botox, in a case hailed as extraordinary by his medical team.</description>
     <link>http://www.physorg.com/news164687986.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 20 Jun 2009 05:40:01 EST</pubDate>
	 <guid isPermaLink="false">news164687986</guid>
</item>
<item>
     <title>Dysport the newest wrinkle-stopping drug to hit market</title>
   	 <description>	There's a new wrinkle remover on the market. Late last month, the U.S. Food and Drug Administration sanctioned Dysport for cosmetic and therapeutic use. Like Botox, it's an injectable drug derived from a botulinum toxin. It has been sold in Europe at a price cheaper than Botox for several years.</description>
     <link>http://www.physorg.com/news161445288.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 13 May 2009 14:55:42 EST</pubDate>
	 <guid isPermaLink="false">news161445288</guid>
</item>
<item>
     <title>New type of botulinum toxin appears to be well tolerated and may help reduce forehead wrinkles</title>
   	 <description>Injections with a new type of botulinum toxin appears to be well tolerated and may help to improve the appearance of moderate to severe forehead lines with no evidence of diminishing treatment response over 13 months, according to a report in the March/April issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals.</description>
     <link>http://www.physorg.com/news156449859.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 16 Mar 2009 19:18:12 EST</pubDate>
	 <guid isPermaLink="false">news156449859</guid>
</item>


</channel>
</rss>

